NCT04924348

Brief Summary

The possible benefits expected from the use of the WALANT procedure are a decrease in intraoperative pain at the surgical site, a decrease in hospitalization time, and a decrease in the time required to lift the anesthesia postoperatively. The risks identified are those inherent to each type of anesthesia (WALANT or traditional ALR), as encountered in current practice, and are therefore not specific to the study: risks related to the local anesthetic agent or risks related to the puncture procedure. The main objective is to determine whether the patient's intraoperative pain at the surgical site is less after a WALANT procedure compared to a traditional ALR procedure (axillary or trunk).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
144

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 2, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2021

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 14, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2022

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2023

Completed
Last Updated

March 10, 2023

Status Verified

March 1, 2023

Enrollment Period

1.2 years

First QC Date

May 24, 2021

Last Update Submit

March 9, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the patient's pain intraoperatively at the surgical site.

    Evaluation of the patient's pain, at the level of the operative site by a visual analog scale from 0 to 10 where 0 equals to "No Pain" and 10 equals to "Extremely severe pain".

    Within 24 hours after intervention

Secondary Outcomes (21)

  • Visual Analog Scale for intraoperative pain at the surgical site

    intraoperative

  • Satisfaction scores

    Within 24 hours after intervention

  • Satisfaction scores

    One day after intervention

  • Assessment of the patient's overall pain after surgery

    One day after intervention

  • Assessment of the patient's overall pain after surgery

    One month after intervention

  • +16 more secondary outcomes

Study Arms (3)

WALANT procedure

EXPERIMENTAL

Local anesthesia of the WALANT type

Procedure: Experimental: WALANT procedure

Axial ALR

ACTIVE COMPARATOR

Axillary loco-regional anesthesia

Procedure: Active Comparator: Axial ALR

Truncal ALR

ACTIVE COMPARATOR

Truncal loco-regional anesthesia

Procedure: Active Comparator: Truncal ALR

Interventions

The WALANT technique, performed under ultrasound, includes two punctures. * The first is a puncture through a medial approach above the wrist and includes two injections. A first subcutaneous injection reproducing a bar above the wrist flexion line, and a second injection above the median nerve. The volumes injected vary from 8 to 10 milliliters (ml). * The second puncture is performed at the base of the palmar surface of the hand and consists of a 10 ml subcutaneous injection of the local anesthetic in order to take advantage of the vasoconstrictive effects of adrenaline, thus allowing the surgical procedure to be performed without a pneumatic tourniquet.

WALANT procedure

The anesthetic protocol in the axillary block consists of performing a puncture, using a needle (50 mm 22G with a short bevel), under the armpit at the level of the axillary hollow after skin disinfection. This puncture, performed under ultrasound, allows the injection of the local anesthetic around the median, radial, ulnar and musculocutaneous nerves. The volume injected per nerve can vary from 5 to 8 ml depending on the visual appreciation during the injection.

Axial ALR

The anesthetic protocol in truncal block consists in injecting the local anesthetic around the median and ulnar nerves by a puncture performed at the elbow or forearm (depending on the practitioner's experience). The volumes injected remain the same and the puncture is also performed under ultrasound guidance. Additional local anesthesia is administered by injecting an additional 5 ml above the wrist flexion line to block the sensory territory of the musculocutaneous nerve.

Truncal ALR

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female patient over 18 years of age
  • Membership in a mandatory health insurance plan
  • Patient treated for a first median nerve liberation surgery at the carpal tunnel
  • Patient having been informed of the study and having given informed consent
  • French-speaking patient

You may not qualify if:

  • Surgical revision
  • Contraindication(s) to loco-regional anesthesia :
  • Coagulation disorder or ongoing anticoagulant therapy
  • Existing peripheral neuropathy
  • Amide-type AL allergy
  • Pregnant or breastfeeding women
  • Inability to undergo the medical follow-up of the study for geographical, social or psychological reasons
  • Patients under legal protection
  • Patients under the influence of drugs that may interfere with the anesthetic techniques under study (cocaine, cannabis, etc. as judged by the investigator)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut de la main Nantes Atlantique

Saint-Herblain, 44800, France

Location

Related Publications (7)

  • Lalonde DH. Conceptual origins, current practice, and views of wide awake hand surgery. J Hand Surg Eur Vol. 2017 Nov;42(9):886-895. doi: 10.1177/1753193417728427. Epub 2017 Sep 8.

    PMID: 28886668BACKGROUND
  • Tulipan JE, Kim N, Abboudi J, Jones C, Liss F, Kirkpatrick W, Rivlin M, Wang ML, Matzon J, Ilyas AM. Open Carpal Tunnel Release Outcomes: Performed Wide Awake versus with Sedation. J Hand Microsurg. 2017 Aug;9(2):74-79. doi: 10.1055/s-0037-1603200. Epub 2017 May 22.

    PMID: 28867906BACKGROUND
  • Lalonde D, Martin A. Tumescent local anesthesia for hand surgery: improved results, cost effectiveness, and wide-awake patient satisfaction. Arch Plast Surg. 2014 Jul;41(4):312-6. doi: 10.5999/aps.2014.41.4.312. Epub 2014 Jul 15.

    PMID: 25075350BACKGROUND
  • Steiner MM, Calandruccio JH. Use of Wide-awake Local Anesthesia No Tourniquet in Hand and Wrist Surgery. Orthop Clin North Am. 2018 Jan;49(1):63-68. doi: 10.1016/j.ocl.2017.08.008.

    PMID: 29145985BACKGROUND
  • Wright J, MacNeill AL, Mayich DJ. A prospective comparison of wide-awake local anesthesia and general anesthesia for forefoot surgery. Foot Ankle Surg. 2019 Apr;25(2):211-214. doi: 10.1016/j.fas.2017.10.015. Epub 2017 Nov 6.

    PMID: 29409279BACKGROUND
  • Fayad F, Lefevre-Colau MM, Gautheron V, Mace Y, Fermanian J, Mayoux-Benhamou A, Roren A, Rannou F, Roby-Brami A, Revel M, Poiraudeau S. Reliability, validity and responsiveness of the French version of the questionnaire Quick Disability of the Arm, Shoulder and Hand in shoulder disorders. Man Ther. 2009 Apr;14(2):206-12. doi: 10.1016/j.math.2008.01.013. Epub 2008 Apr 23.

    PMID: 18436467BACKGROUND
  • Estebe JP, Gentili ME, Langlois G, Mouilleron P, Bernard F, Ecoffey C. Lidocaine priming reduces tourniquet pain during intravenous regional anesthesia: A preliminary study. Reg Anesth Pain Med. 2003 Mar-Apr;28(2):120-3. doi: 10.1053/rapm.2003.50123.

    PMID: 12677622BACKGROUND

Related Links

MeSH Terms

Conditions

Median Neuropathy

Condition Hierarchy (Ancestors)

MononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Flore-Anne LECOQ, MD

    Institut de la Main Nantes Atlantique

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Interventional, prospective, therapeutic, comparative, randomized controlled open-label, non-inferiority, single-center, national study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 24, 2021

First Posted

June 14, 2021

Study Start

December 2, 2020

Primary Completion

February 15, 2022

Study Completion

January 25, 2023

Last Updated

March 10, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations